Chairman of the Board of Directors
Mr.
Rash, a co-founder of
APP, has over 30 years of
experience in
healthcare services. Mr. Rash is Chairman and CEO of
RegionalCare
Hospital Partners, Inc., a hospital company that he recently founded
and for which he raised $300 million of equity from New York-based
Warburg Pincus. Previously, he was Chairman
and CEO of
Province Healthcare Company, which he founded as a start-up in 1996
backed by Chicago-based GTCR. Under his
direction, Province completed a successful IPO in 1998 and grew
to 21 hospitals across the U.S. with
revenues of nearly $1 billion by 2004 when it was sold to Lifepoint
Hospitals, Inc. (NASDAQ: LPNT) for $1.7 billion. Previously, Mr. Rash
was Executive Vice President and COO at Community Health Systems, Inc.
(NYSE: CYH). During
his tenure there, he led the growth of the company from 10 to 41
hospitals in 17 states. Mr. Rash was an early investor in Odyssey
Healthcare, one of the largest hospice companies in the U.S. and is
currently a board member of HealthSpring, Inc. (NYSE: HS), a managed
care
organization. Mr. Rash was
also past Chairman of the Federation of American Hospitals and the
Nashville Health Care Council. Mr. Rash holds a bachelors degree and an
MBA from Middle Tennessee State University. BackRobert A. Yeager
Chief Executive Officer
Board Member
Mr. Yeager, a co-founder, has
over 30 years of experience
in healthcare
services. Prior to APP, he was Chairman of Attentus Healthcare Company,
an operator of rural acute care hospitals, which he co-founded.
Previously, he was President and CEO of OrthoLink Physicians
Corporation, one of the largest providers of physician management
services for orthopedic and sports-medicine doctors, backed by
Welsh Carson Anderson & Stowe. OrthoLink was one of the few
successful physician practice management companies to grow and survive
in a difficult macro environment. The company provided services for over 200
physicians across the country. Prior to OrthoLink, Mr. Yeager was
Executive Vice President and CFO of Quorum Health Group, a large
hospital management company founded as a spin-off of HCA and backed by
Welsh Carson Anderson & Stowe. At Quorum, Mr. Yeager completed
a
$115 million IPO and raised over $200 million of debt capital.
Previously, he held several positions with Hospital Corporation of
America (HCA), including hospital CFO, Regional AVP, and VP/Controller
of HCA Management Company which ultimately was spun off to form
Quorum. Mr. Yeager is a CPA (inactive) and holds a BBA from Middle
Tennessee State University. BackRobert A. Mignatti
Chief Operating Officer
Mr. Mignatti has over 30
years of
experience in the
pathology, laboratory and diagnostics fields. Most recently, Mr.
Mignatti was President and COO of Exagen Diagnostics, Inc, Albuquerque,
New Mexico an emerging molecular diagnostics company developing a new
class of prognostic genomic assays. Previously, Mr. Mignatti was
Executive Vice President and COO at Esoterix, Inc., Austin, Texas, a
leading provider of molecular, oncology, endocrinology, coagulation and
identity
testing services. During his eight-year tenure there, the company grew
to an organization with over 800 employees and $120 million of revenue.
Mr. Mignatti had full P&L responsibility, managed 10 separate
laboratory facilities, and was responsible for strategic planning,
acquisitions and any subsequent integration of
acquisitions, sales and marketing and business development. After the
$150 million sale of Esoterix to Laboratory Corporation of America
(NYSE: LH) in May 2005, Mr. Mignatti also assisted in the
post-transaction integration. Prior to Esoterix, Mr.
Mignatti was President and owner of Allergy Testing Laboratory, Inc.,
which he co-founded in 1988 and ultimately sold to Esoterix in 1997.
His experience also includes management positions as Senior Vice
President in charge of worldwide marketing and North American Sales for
Kallestad Diagnostics from 1978 through its sale to Sanofi Diagnostic
Pasteur in 1987. Mr. Mignatti holds a BBA from LaSalle
College. Back
Edward
D. Dooling, Jr.
Chief Growth Officer
Executive Vice President of
Sales & Marketing
Mr. Dooling, a co-founder of
APP, has 20 years experience
of
successfully growing and leading pathology and diagnostic service
companies. As the Chief Growth Officer, Mr. Dooling is responsible for
all growth initiatives for the company and our partner labs. Prior to
APP, Mr. Dooling was President and CEO of Resonance Health, a
publicly-traded Australian company focused on imaging technology.
Previously,
Mr. Dooling also served as COO of Asterand, Inc., a provider of
bio-material to pharmaceutical and biotech companies. Prior to
Asterand, Mr. Dooling was Vice President and General Manager of the
Anatomic Pathology Division of AmeriPath, Inc. where he managed 25
sales
representatives and several regional sales managers and business
development personnel. Under his leadership, the AP division became the
top performing division within AmeriPath. Prior to AmeriPath, Mr.
Dooling was Vice President of Sales & Marketing at Pathology
Consultants of America, Inc., an anatomic pathology company with 10
laboratories, which was ultimately acquired by AmeriPath. Previously,
Mr. Dooling spent 10 years with DIANON Systems, Inc. which he joined as
a sales representative and quickly established himself as a top
performer within the company receiving numerous awards and promotions.
He ultimately became Vice President of Sales & Marketing,
leading a 50+ member sales and marketing team that was
widely-considered to be one of the most effective
anatomic pathology sales organizations in the U.S. Mr. Dooling spent
four years in the U.S. Navy where he was
recognized as top performing junior officer on board the U.S.S. Iowa.
Mr. Dooling holds a BS in computer
science from Villanova University. Back
Thanasis
Papaioanu
Chief
Development Officer
Executive Vice President
of
Information & Technology
Thanasis, a
co-founder of APP, has 15 years of experience in finance
and mergers & acquisitions, including several years of
financial,
transactional and operational experience with anatomic pathology
laboratories.
Prior to APP, Thanasis was a Managing Director at Harpeth Capital, LLC,
a Nashville-based investment banking firm, focusing on
healthcare services including labs, hospitals,
dialysis clinics, and healthcare IT.
Previously, he served as CFO of Innovative Pathology Services, PLLC, an
anatomic pathology practice serving several hospitals and physician
offices with 12 pathologists. Prior to IPS, he was a Director at FTN
Midwest, the investment banking subsidiary of First Horizon Bank (NYSE:
FHN) and a Director at SunTrust Robinson Humphrey, the investment
banking subsidiary of SunTrust Banks (NYSE: STI), where he was a senior
member of the Mergers & Acquisitions Group and the Technology
Group. Thanasis has been
involved in over 40 completed merger & acquisition and
financing
transactions totaling to over $1 billion in transactional value. One of
his former lab clients includes CBLPath, Inc., a large pathology
lab company based in New York. Thanasis is a member of the American Pathology Foundation. He holds a BS in
electrical engineering from Florida Institute of Technology, an MS in
electrical engineering and an MS in systems science & mathematics from Washington
University in St. Louis, and an MBA from Emory University. Back
Lee
C. Dilworth
Executive
Vice President
Chief Legal &
Administrative
Officer
Mr. Dilworth has over 20
years of legal experience as a
corporate and
healthcare transactional attorney. Prior to joining APP, he was Senior
Vice President and General Counsel of Attentus Healthcare Company, an
operator of rural acute care hospitals, where he was responsible
company-wide for legal, development, compliance, information security,
and risk management matters. Previously, he was a Member, Managing
Partner and Chair of the Corporate Practice at Harwell Howard Hyne
Gabbert & Manner, P.C. (H3GM), a Nashville, Tennessee-based law
firm specializing in advising private and public healthcare clients on
various strategic transactions. During his 18 year tenure at H3GM, Mr.
Dilworth was involved in numerous public and private company
M&A
transactions, including approximately 75 hospital acquisitions and
divestitures, multiple physician joint ventures, and representation of
specialty physician groups throughout the southeastern U.S. Mr.
Dilworth was a founder of Health & Productivity Corporation of
America, a provider of integrated health and health-related
productivity and disease management services. Mr. Dilworth is listed in
editions of The Best Lawyers in America and America’s Leading Business
Lawyers. Mr. Dilworth holds a BA in business administration from Furman
University, a JD from the University of Georgia School of Law, and a
LL.M in taxation from New York University School of Law. Back
John
I. Starling
Chief
Financial Officer
Mr. Starling has over 20
years of
accounting and taxation experience that spans two of the largest
accounting firms in the world as well as
public and large venture-backed companies with large, complex,
multi-facility operations. Prior to joining APP, Mr. Starling served as
Vice President Taxation/Finance at Emdeon Business Services, LLC and,
immediately prior to that, at Attentus Healthcare Company. Previously,
Mr. Starling was Vice President of Taxation for Province Healthcare
Company, a publicly-traded hospital company with nearly $1 billion of
revenue. Mr. Starling’s prior work experience includes over five years
with the public accounting firms Arthur Andersen & Co., and
KPMG Peat Marwick serving clients in healthcare and other industries.
Mr.
Starling holds a BS in accounting from Lipscomb University and a
Masters of Accountancy from the University of Tennessee. Back
Tricia
Hughey
Chief
Executive Officer, UniPath
Denver,
Colorado
Ms. Hughey has over 30 years
of progressive experience in
the
administration and operations of anatomic pathology laboratories. Ms.
Hughey is currently the CEO of UniPath, a 25-pathologist anatomic
pathology laboratory based in Denver, Colorado. During her 12-year
tenure as CEO of UniPath, Ms. Hughey has implemented business
development initiatives in cytology, histology, immunohistochemistry,
flow cytometry and molecular pathology. Previously, she has held
management and laboratory positions with other anatomic pathology
groups, including Pathology Partners (now Caris Diagnostics), as well
as hospital clinical laboratories. Ms. Hughey is an active speaker at
several national pathology conferences, including The Executive War
College (The Dark Report), Washington G2 Conferences, American
Pathology Foundation, and CAP. Ms. Hughey has been a member of the
Pathology Management Assembly of MGMA since 1985, and was a member on
the committee providing recommendations for CLIA 88 guidelines. She was
also one of the first non-physicians appointed by the CAP Board of
Governors to one of their committees; and she continues to serve on the
CAP Practice Management Committee. She is also a member of the Board of
Directors of the American Pathology Foundation. Ms. Hughey holds a BA
in business administration and economics from Regis College. Back
